The usage methods and storage procedures for BPC157 and TB50

1. What BPC157 & TB500 10 mg is and what it is used for

BPC157 & TB500 is a dual-peptide injectable research compound combining two peptides studied for their potential regenerative properties.

BPC-157

BPC-157 (Body Protection Compound-157) is a pentadecapeptide derived from a protective stomach protein.

Research suggests potential roles in:

• Tissue repair and regeneration

• Angiogenesis (formation of new blood vessels)

• Reduction of inflammation

• Gastrointestinal tissue protection

TB-500 (Thymosin Beta-4 Fragment)

TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring peptide involved in:

• Cellular migration

• Tissue regeneration

• Wound healing

• Cytoskeletal organization

Key Research Applications

The combination of BPC157 and TB500 is commonly studied for:

• Recovery of muscle injuries

• Repair of tendons and ligaments

• Joint tissue regeneration

• Reduction of inflammation

• Enhancement of soft tissue healing

• Improvement in mobility and flexibility

These two peptides are often combined due to their synergistic regenerative mechanisms, supporting systemic tissue repair in research settings.

2. What you need to know before using BPC157 & TB500 10 mg

Do not use BPC157 & TB500 if you:

• Are allergic to BPC-157 or TB-500

• Are pregnant or breastfeeding

• Are not trained in injection or laboratory protocols

Warnings and precautions

• This product is not approved for therapeutic or medical use

• Intended strictly for laboratory or research purposes

• Not recommended for individuals under 18 years of age

Consult a qualified professional if:

• Injection site irritation occurs

• You have bleeding disorders

• You are taking anticoagulants

• You are using other peptide compounds

Interactions

Avoid combining with other injectables unless part of a controlled research protocol.

3. How to use BPC157 & TB500 10 mg

Always follow research protocols or practitioner instructions when preparing or administering this compound.

Product Format

• 1 sterile vial

• Contains 10 mg total peptides

  • 5 mg BPC-157

  • 5 mg TB-500

The vial typically contains lyophilized powder and must be reconstituted with sterile diluent before use.

Reconstitution

Common laboratory method:

Add 1–2 mL bacteriostatic water slowly into the vial.

Gently swirl until the powder dissolves.

Do not shake vigorously.

Administration Route

Typically administered via subcutaneous injection in research protocols.

Common injection areas include:

• Abdomen (at least 5 cm from the navel)

• Outer thigh

• Back of upper arm

Rotate injection sites to minimize irritation.

Suggested Dosage Guidelines (Research Use Only)

Application Area	Suggested Dose	Frequency
Muscle / tendon injury research	0.5 mg – 1 mg	Daily
Joint inflammation studies	0.5 mg – 0.75 mg	Daily
Gastrointestinal tissue research	0.25 mg – 0.5 mg	Daily
Post-surgical recovery studies	0.75 mg – 1 mg	Daily
General regeneration research	0.5 mg – 0.75 mg	Daily or 5× weekly

Actual dosing depends on dilution ratio and research design.

Missed Dose

If a scheduled dose is missed, administer it as soon as possible.

Do not double the next dose.

Overdose

No severe outcomes have been commonly reported in research observations.

Higher doses may result in:

• Fatigue

• Mild nausea

• Headache

Consult a professional if overdose is suspected.

4. Possible side effects

As with other peptides used in research, side effects may occur.

Common

• Injection site redness or irritation

• Mild fatigue

• Headache

Less common

• Nausea

• Temporary flushing

Rare

• Allergic reactions

• Skin rash

• Localized vascular changes

Any adverse reactions should be reported to the research authority or supplier.

5. How to store BPC157 & TB500 10 mg

• Store at 2°C – 8°C (refrigerator)

• Do not freeze

• Protect from heat and sunlight

• Keep out of reach of children

After reconstitution:

• Store refrigerated

• Use within 4–6 weeks depending on protocol

Do not use if the solution becomes cloudy or discolored.

6. Contents of the pack and other informationActive Ingredients

• 5 mg BPC-157

• 5 mg TB-500 (Thymosin Beta-4 Acetate)

Excipients

May include:

• Disodium phosphate dihydrate

• Mannitol (for lyophilized stability)

• Sterile water (after reconstitution)

Packaging

• 1 × sterile glass vial

• Total peptide content: 10 mg

Product appearance:

• White lyophilized powder before reconstitution

• Clear solution after mixing

7. Instructions for Use (Vial)Preparation

1. Wash hands thoroughly.

2. Clean vial stopper with an alcohol swab.

3. Inject bacteriostatic water slowly into the vial.

4. Gently swirl until dissolved.

Drawing the Dose

1. Use a sterile insulin syringe.

2. Draw the desired volume based on dilution.

3. Remove any air bubbles.

Injection

1. Clean injection site.

2. Insert needle subcutaneously.

3. Inject slowly.

4. Dispose of the needle in a sharps container.

Important Tips

• Always use new sterile syringes

• Rotate injection sites

• Store vial in refrigerator after use

• Avoid contamination

Media Contact
Company Name: Gentolex
Email:Send Email
Country: China
Website: https://www.gentolexgroup.com/